Supply Issues Greiner Bio-One Ltd Venous Serum Tubes (ICN 2996)

Change:

• The supplier Greiner Bio-One Ltd has informed us of a supply issue with its Venous Serum Tube products.
• There are 13 product codes affected.
• A contamination issue occurred during manufacturing, so manufacturing was temporarily paused. This has now resumed but there will be some knock-on impacts to get stock into the network.
• Due to this ongoing supply issue some of these products are now being threshold managed as they are subject to Protect Demand Management.

Impact:          

• KFK342, KFK383 and KFK061 are currently suspended and unavailable to order.
• KFK259, KFK059, KFK304 and KFK208 are subject to Protect Demand Management.
• Six remaining products are currently subject to intermittent supply.
• The products subject to Protect Demand Management are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• The supply issue is anticipated to be resolved by 25 July 2025.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• The supplier has issued a customer letter below, listing the most impacted codes that are currently suspended or have low stock in our network also at risk of being suspended.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.